Optimizing Oncology Care: How Accredo’s TRC Empowers Pharma Manufacturers
Future-Ready Oncology Support for Pharma Manufacturers
Helping new therapies make it to market is just one part of how we support oncology care at Accredo. We are constantly looking for new ways to improve every step of the journey – from launch, through delivery, administration and beyond.
Our Oncology Therapeutic Resource Center® (TRC) works with manufacturers, prescribers and patients to understand their needs and meet them with oncology-tailored tools and practices. The dedicated specialists within our TRC look to take oncology into the future, with new research and digital resources - enhancing experiences and enabling innovation that will raise the standards for patient outcomes.
Using Real-World Evidence to Advance Oncology Care
Today’s best practices were built on a foundation of years of research. That’s why the oncology specialists and other clinicians working in our Oncology TRC continue to enhance care protocols with real-world evidence. We pay close attention after each new product launch to better support the patients. We proactively look for places to incrementally improve, conducting new research to uncover emerging breakthroughs and gaps in patient and caregiver support.
Our approach to research is grounded in hands-on patient engagement and focuses on the four biggest challenges in oncology:
- Health: improving outcomes and raising quality of care
- Experiences: improving access to and navigation of the health care system
- Equity: uncovering new ways to ensure oncology care addresses social determinants of health (SDOH)
- Value: identifying ways to lower cost of care for patients and payers
By continually pioneering new approaches to oncology, our Oncology Therapeutic Resource Center aims to make battling cancer a more compassionate and hopeful experience.
Digital Tools That Streamline Oncology Therapies
“Only Accredo has such an outstanding resource for their pharma partners.” – Oncology Therapy Manufacturer
Our best-in-class digital tools do more than streamline and consolidate data – they help manufacturers improve tomorrow’s prescriptions with unparalleled insights into today’s processes.
Manufacturing field agents find value in streamlining the referral process with in-app management, prior authorization support and easy access to on-the-go information. This data provides enhanced visibility into all aspects of the business, allowing manufacturers to make more informed decisions.
The Pharma Hub Portal from Accredo Specialty Pharmacy also dramatically reduces the time needed to resolve common questions about prescriptions. In fact, 93% of queries are resolved on the Pharma Hub Portal, reducing the need to escalate issues up to program managers, and saving prescribers and their assistants a much-needed average of 24 hours a week – valuable time they can put back into patient care.
How Accredo Supports Oncology Prescribers with Digital Access
- 75% of specialty prescribers in the U.S. are registered on MyAccredoPatients.com.
- More than 2,000 more join every month.
MyAccredoPatients.com supports prescribers with the tools they need for faster, better oncology care, offering the ability to:
- Check prescription status and shipments
- View patient summaries
- Find real-time assistance from Accredo agents
The website also allows prescribers and their assistants to upload clinical supporting documents, access nursing notes from home visits and complete real-time pharmacy benefit checks to verify the patient’s tests or insurance cards. These tools allow prescribers to focus on what they do best: helping patients battle cancer.
Uniting with Pharma for Continuous Oncology Innovation
Providing the right tools and information to our partners is only the beginning. We’re dedicated to improving oncology with ongoing collaboration and support at every step of the therapeutic process.
To learn more about how our TRC is preparing today for tomorrow’s oncology challenges, download the Oncology TRC Whitepaper here The Right Specialty Pharmacy for Oncology Therapies.
